Mubadala Investment Company PJSC has announced the launch of its new life sciences subsidiary, Mubadala Bio. This initiative aims to strengthen domestic drug manufacturing and position Abu Dhabi as a regional hub for biopharma innovation.

Mubadala Bio will concentrate on the production and distribution of therapeutic products, with a key focus on enhancing national drug security and supporting the UAE’s economic diversification agenda. The company boasts an integrated portfolio that includes 10 manufacturing and distribution facilities located across Asia, Africa, and Europe, with six of these facilities situated within the UAE.

The facilities cover a total area of 110 000 square metres and have an impressive annual production capacity of over 2.5 billion tablets and capsules, as well as 120 million intravenous and injectable units. These products are distributed to more than 100 countries. Mubadala Bio’s extensive product portfolio includes over 10 000 medical products, spanning a wide array of therapy areas and catering to the full continuum of care—from prevention and diagnosis to treatment and supportive care.

In addition to its manufacturing capabilities, Mubadala Bio plans to forge strategic partnerships with global life sciences firms and academic institutions. These partnerships will focus on fostering local biopharma innovation, talent development, and enhancing pharmaceutical logistics infrastructure. The launch of Mubadala Bio is in alignment with the UAE Centennial 2071 vision and will be officially presented at the upcoming Make it in the Emirates 2025 event, which serves as the national industrial showcase.

According to Gulf News, Dr. Bakheet Al Katheeri, CEO of Mubadala’s UAE Investments Platform, said that the launch represents “a transformative step” towards reinforcing healthcare resilience and promoting long-term economic growth. Mubadala Bio is classified as one of Mubadala’s designated “National Champions,” entities established to support strategic sectors that align with the UAE’s long-term development goals. Through its initiatives, the company aims to accelerate the UAE’s transition to a knowledge-based economy, particularly in the fields of healthcare and biotechnology.